<DOC>
	<DOCNO>NCT01862289</DOCNO>
	<brief_summary>Most asthmatic patient remain uncontrolled despite inhaled steroid treatment . Chronic hyperventilation syndrome ( also call Idiopathic Hyperventilation ) occur 20 40 % asthmatic patient . The purpose study assess prevalence chronic hyperventilation syndrome specific population difficult-to-treat asthmatic patient , receive daily high dos inhale steroid ( ≥ 1000 µg fluticasone additional treatment long-acting beta 2-agonist ( LABA ) remain uncontrolled ( Asthma control test ( ACT ) &lt; 18 ) . We plan realize systematic assessment diagnosis chronic hyperventilation syndrome Nijmegen questionnaire , blood gas rest , hyperventilation test Cardiopulmonary Exercise Testing ( CPET ) . We also collect demographic information well information asthma history , asthma control treatment .</brief_summary>
	<brief_title>Prevalence Hyperventilation Syndrome Difficult Asthma</brief_title>
	<detailed_description>There one visit . During visit , patient complete self-questionnaires like Nijmegen , Hospital Anxiety Depression Scale ( HAD ) , Short-Form 36 ( SF36 ) , Asthma Quality Life Questionnaire ( AQLQ ) , The participant baseline spirometry fractional exhale nitric oxide measure expiratory flow 50 mL/s ( FENO50 ) , blood gas rest , hyperventilation challenge Cardiopulmonary Exercise Testing ( CPET ) determine accurately presence chronic hyperventilation syndrome . The diagnosis confirm two positive test ( Nijmegen , Hyperventilation challenge blood gas ) final decision medical committee . The first step determine prevalence oh syndrome specific population . The second step assess sensitivity , specificity , false positive rate false negative rate different parameter measure test .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Hyperventilation</mesh_term>
	<criteria>men woman , age 18 , non smoker two year longer , less 10 pack/years smoke history , physiciandiagnosed asthma , uncontrolled asthma Asthma control test ( ACT ) &lt; 18 , historical FEV1 reversibility , daily inhaled steroid treatment least 2000microg eq beclomethasone , Forced expiratory volume 1 second ( FEV1 ) &gt; 50 % predict value chronic pulmonary disease , vocal cord dysfunction , pregnancy , Participation another interventional research trial , unable provide consent , asthma exacerbation within last 4 week</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>difficult asthma</keyword>
	<keyword>hyperventilation syndrome</keyword>
	<keyword>prevalence</keyword>
</DOC>